Mytozytrex
Active Ingredient(s): MitomycinFDA Approved: * November 14, 2002
Pharm Company: * SUPERGEN
Category: Cancer
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Mytozytrex Overview
The mitomycins are a family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.[1][2] They include mitomycin A, mitomycin B, and mitomycin C. When the name mitomycin occurs alone, it usually refers to mitomycin C, its international nonproprietary name. Mitomycin C is used as a medicine for treating various disorders associated with the growth and spread of cells. Contents 1 Biosynthesis 2 Biological effe...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Mitomycin
Recent Mytozytrex Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Mitomycin
- For Solution: 0.2mg, 0.2mg/vial
- Injection: 10mg, 20mg, 20mg/vial, 40mg, 40mg/vial, 5mg, 5mg/vial
- Powder: 40mg/vial